In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes
Antimicrobial Agents and Chemotherapy · 05.12.2024 · 68 (12)
DOI: 10.1128/aac.01307-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.12.2024. Verfasst von Salud Rodríguez-Pallares und 12 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain. Hauptthemen laut MEDLINE: Ceftazidime, Azabicyclo Compounds, beta-Lactamases, Drug Combinations. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MEC | Instituto de Salud Carlos III (ISCIII), Axencia Galega de Innovación (GAIN), Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC).
Abstract (Originalsprache)
We describe the in vivo emergence of resistance to ceftazidime/avibactam via modification of AmpC in a clinical Klebsiella aerogenes isolate during therapy with this combination. Paired ceftazidime/avibactam-susceptible/resistant isolates were obtained before and during ceftazidime/avibactam treatment. Whole genome sequencing revealed a differential mutation in AmpC (R148W) in the ceftazidime/avibactam-resistant isolate. Molecular cloning and structural studies confirmed the impact of this substitution, which affects the architecture of the H10 helix, on the evolved resistant phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
- Departamento de Química Orgánica, Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
- Servicio de Microbiología and Instituto de Innovación e Investigación Biomédica de Cádiz (INIBICA), Hospital Universitario Puerta del Mar, Cádiz, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Salud Rodríguez-Pallares, Fátima Galán-Sánchez, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez
Förderung
- MEC | Instituto de Salud Carlos III (ISCIII)
- Axencia Galega de Innovación (GAIN)
- Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC)
- MEC | Agencia Estatal de Investigación (AEI)
- Xunta de Galicia (Regional Government of Galicia)
- Centro Singular de Investigación de Galicia
Zitieren
APA
Rodríguez-Pallares, S., Blanco-Martín, T., Lence, E., Aja-Macaya, P., Sánchez-Peña, L., González-Pinto, L., Rodríguez-Mayo, M., Fernández-González, A., Galán-Sánchez, F., Beceiro, A., González-Bello, C., Bou, G., & Arca-Suárez, J. (2024). In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes. Antimicrobial Agents and Chemotherapy, 68(12). https://doi.org/10.1128/aac.01307-24
Vancouver
Rodríguez-Pallares S, Blanco-Martín T, Lence E, Aja-Macaya P, Sánchez-Peña L, González-Pinto L, et al. In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes. Antimicrobial Agents and Chemotherapy. 2024;68(12). doi:10.1128/aac.01307-24
BibTeX
@article{RodrguezPallares2024,
author = {Rodríguez-Pallares, Salud and Blanco-Martín, Tania and Lence, Emilio and Aja-Macaya, Pablo and Sánchez-Peña, Lucía and González-Pinto, Lucía and Rodríguez-Mayo, María and Fernández-González, Ana and Galán-Sánchez, Fátima and Beceiro, Alejandro and González-Bello, Concepción and Bou, Germán and Arca-Suárez, Jorge},
title = {In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {12},
doi = {10.1128/aac.01307-24}
}
EUVIMED